All Stories

  1. Vascular dysfunctions during radiation retinopathy
  2. Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target
  3. Exploiting radiation immunostimulatory effects to improve glioblastoma outcome
  4. Microvalve bioprinting as a biofabrication tool to decipher tumor and endothelial cell crosstalk: Application to a simplified glioblastoma model
  5. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma
  6. Towards a Reduced In Silico Model Predicting Biochemical Recurrence After Radiotherapy in Prostate Cancer
  7. SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cells
  8. Altered Macrophage Function Associated with Crystalline Lung Inflammation in Acid Sphingomyelinase Deficiency
  9. Mechanistic Simulation of Tumor Response Outperforms Radiomics Predicting Recurrence in Prostate Cancer Radiotherapy
  10. 53BP1 Repair Kinetics for Prediction of In Vivo Radiation Susceptibility in 15 Mouse Strains
  11. Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model
  12. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis
  13. Secretion of Acid Sphingomyelinase and Ceramide by Endothelial Cells Contributes to Radiation-Induced Intestinal Toxicity
  14. Caveolin-1 regulates the ASMase/ceramide-mediated radiation response of endothelial cells in the context of tumor–stroma interactions
  15. Exercise training improves radiotherapy efficiency in a murine model of prostate cancer
  16. Influence of Radiotherapy Fractionation Schedule on the Tumor Vascular Microenvironment in Prostate and Lung Cancer Models
  17. Establishing mechanisms affecting the individual response to ionising radiation
  18. Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy
  19. Impairing temozolomide resistance driven by glioma stem‐like cells with adjuvant immunotherapy targeting O‐acetyl GD2 ganglioside
  20. Reoxygenation during radiotherapy in intermediate-risk prostate cancer
  21. PO-0969 Sensitivity analysis of an in silico model of prostate tumour growth and response to radiotherapy
  22. Sensitivity Analysis Of An In Silico Model Of Tumor Growth And Radiation Response
  23. Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
  24. EP-1998: In silico modelling of the impact of the fractionation for hypofractionated prostate treatments
  25. A new tissue segmentation method to calculate 3D dose in small animal radiation therapy
  26. Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study
  27. Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside
  28. Ionizing radiation induces long-term senescence in endothelial cells through mitochondrial respiratory complex II dysfunction and superoxide generation
  29. The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells
  30. Optimizing radiotherapy protocols using computer automata to model tumour cell death as a function of oxygen diffusion processes
  31. Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis
  32. TargetingO-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
  33. Rapid Diminution in the Level and Activity of DNA-Dependent Protein Kinase in Cancer Cells by a Reactive Nitro-Benzoxadiazole Compound
  34. Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
  35. Oxidative stress disassembles the p38/NPM/PP2A complex, which leads to modulation of nucleophosmin-mediated signaling to DNA damage response
  36. Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan
  37. Krüppel-like factor 4: A new potential biomarker of lung cancer
  38. Validation of fast Monte Carlo dose calculation in small animal radiotherapy with EBT3 radiochromic films
  39. Radiothérapie hypofractionnée : quelles sont les règles à suivre ?
  40. Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling
  41. Bioactive lipids and the control of Bax pro-apoptotic activity
  42. Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
  43. Underestimation of dose delivery in preclinical irradiation due to scattering conditions
  44. Improved Functionality of the Vasculature during Conventionally Fractionated Radiation Therapy of Prostate Cancer
  45. Membrane Signaling Induced by High Doses of Ionizing Radiation in the Endothelial Compartment. Relevance in Radiation Toxicity
  46. Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo
  47. Corrigendum to “Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions” [Radiother Oncol 106 (2013) 138–146]
  48. Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting
  49. Re-orienting the immune system
  50. Differentiation-Related Response to DNA Breaks in Human Mesenchymal Stem Cells
  51. Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions
  52. Anti-Gb3 Monoclonal Antibody Inhibits Angiogenesis and Tumor Development
  53. Toxicité rectale de la radiothérapie : signes cliniques, physiopathologie et prise en charge
  54. Radiobiologie appliquée à l’endothélium
  55. Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review
  56. RhoA GTPase regulates radiation-induced alterations in endothelial cell adhesion and migration
  57. A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
  58. Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy
  59. S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism
  60. Sphingosine-1-Phosphate Activates the AKT Pathway to Protect Small Intestines from Radiation-Induced Endothelial Apoptosis
  61. « Dose-painting » : mythe ou réalité ?
  62. Plasma membrane signaling induced by ionizing radiation
  63. Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen-Expressing Medullary Thyroid Cancer Xenograft
  64. Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis
  65. Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma
  66. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms
  67. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL‐6 and survival of stage III melanoma patients treated with tumour‐infiltrating lymphocytes
  68. A Systematic Review of Epidemiological Associations between Low and Moderate Doses of Ionizing Radiation and Late Cardiovascular Effects, and Their Possible Mechanisms
  69. Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen
  70. Radiothérapie interne vectorisée : seule ou en association ?
  71. Sphingosine-1-Phosphate Protects Proliferating Endothelial Cells from Ceramide-Induced Apoptosis but not from DNA Damage-Induced Mitotic Death
  72. Intestinal Epithelial Cell Dysfunction is Mediated by an Endothelial-Specific Radiation-Induced Bystander Effect
  73. Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-β1-dependent pathway
  74. Multiple Trichoepitheliomas in the Lines of Blaschko
  75. Erratum: Corrigendum: ATM regulates target switching to escalating doses of radiation in the intestines
  76. ATM regulates target switching to escalating doses of radiation in the intestines
  77. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
  78. Erratum: Streptococcus pyogenes and phagocytic killing
  79. Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring
  80. Insertional Mutagenesis of the Mouse Acid Ceramidase Gene Leads to Early Embryonic Lethality in Homozygotes and Progressive Lipid Storage Disease in Heterozygotes
  81. Correlation between antioxidant status, tumorigenicity and radiosensitivity in sister rat cell lines
  82. Insertional Mutagenesis of the Mouse Acid Ceramidase Gene Leads to Early Embryonic Lethality in Homozygotes and Progressive Lipid Storage Disease in Heterozygotes
  83. Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
  84. Ceramide Enables Fas to Cap and Kill
  85. Comment bloquer l'apoptose des ovocytes.
  86. Natural Ceramide Reverses Fas Resistance ofAcid Sphingomyelinase−/−Hepatocytes
  87. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine -1-phosphate therapy
  88. CD95-mediated apoptosis in vivo requires acid sphingomyelinase
  89. Role of Acidic Sphingomyelinase in Fas/CD95-mediated Cell Death
  90. Enhanced Expression of the Kin17 Protein Immediately after Low Doses of Ionizing Radiation